The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Predicting commercially available antiviral drugs that may act on the novel coronavirus (SARS-CoV-2) through a drug-target interaction deep learning model
Open accessPublished version of a preprint
Abstract
The infection of a novel coronavirus found in Wuhan of China (2019-nCoV) is rapidly spreading, and the incidence rate is increasing worldwide. Due to the lack of effective treatment options for 2019-nCoV, various strategies are being tested in China, including drug repurposing. In this study, we used our pretrained deep learning-based drug-target interaction model called Molecule Transformer-Drug Target Interaction (MT-DTI) to identify commercially available drugs that could act on viral proteins of 2019-nCoV. The result showed that atazanavir, an antiretroviral medication used to treat and prevent the human immunodeficiency virus (HIV), is the best chemical compound, showing a inhibitory potency with K d of 94.94 nM against the 2019-nCoV 3C-like proteinase, followed by efavirenz (199.17 nM), ritonavir (204.05 nM), and dolutegravir (336.91 nM). Interestingly, lopinavir, ritonavir, and darunavir are all designed to target viral proteinases. However, in our prediction, they may also bind to the replication complex components of 2019-nCoV with an inhibitory potency with K d < 1000 nM. In addition, we also found that several antiviral agents, such as Kaletra, could be used for the treatment of 2019-nCoV, although there is no real-world evidence supporting the prediction. Overall, we suggest that the list of antiviral drugs identified by the MT-DTI model should be considered, when establishing effective treatment strategies for 2019-nCoV.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trott, O., & Olson, A. J. (2010) · Journal of Computational Chemistry · doi:10.1002/jcc.21334 · Cited by 38,412
AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibility
Morris, G. M., Huey, R., Lindstrom, W., Sanner, M. F., Belew, R. K., Goodsell, D. S., & Olson, A. J. (2009) · Journal of Computational Chemistry · doi:10.1002/jcc.21256 · Cited by 25,486
Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia
Li, Q., Guan, X., Wu, P., Wang, X., Zhou, L., Tong, Y., Ren, R., Leung, K. S. M., Lau, E. H. Y., Wong, J. Y., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001316 · Cited by 16,575
Open Babel: An open chemical toolbox
O'Boyle, N. M., Banck, M., James, C. A., Morley, C., Vandermeersch, T., & Hutchison, G. R. (2011) · Journal of Cheminformatics · doi:10.1186/1758-2946-3-33 · Cited by 10,939
Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hu, Z., Zhong, W., & Xiao, G. (2020) · Cell Research · doi:10.1038/s41422-020-0282-0 · Cited by 6,958
First case of 2019 novel coronavirus in the United States
Holshue, M. L., DeBolt, C., Lindquist, S., Lofy, K. H., Wiesman, J., Bruce, H., Spitters, C., Ericson, K., Wilkerson, S., Tural, A., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001191 · Cited by 6,030
Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
Zaki, A. M., van Boheemen, S., Bestebroer, T. M., Osterhaus, A. D. M. E., & Fouchier, R. A. M. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1211721 · Cited by 5,735
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
Jin, Z., Du, X., Xu, Y., Deng, Y., Liu, M., Zhao, Y., Zhang, B., Li, X., Zhang, L., Peng, C., et al. (2020) · Nature · doi:10.1038/s41586-020-2223-y · Cited by 4,358
SARS and MERS: recent insights into emerging coronaviruses
de Wit, E., van Doremalen, N., Falzarano, D., & Munster, V. J. (2016) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2016.81 · Cited by 3,510
Yao, X., Ye, F., Zhang, M., Cui, C., Huang, B., Niu, P., Liu, X., Zhao, L., Dong, E., Song, C., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa237 · Cited by 2,662
Research works printed but not linked: 4
- Wang M., Cao R., Zhang L., Yang X., Liu J., Xu M. et al: Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. Cell Res 2020; .
- Z. Jin X. Du Y. Xu Y. Deng M. Liu Z. Zhao et al. Structure of Mpro from COVID-19 virus and discovery of its inhibitors. bioRxiv. 2020.
- Dayer M.R., Taleb-Gassabi S. and Dayer M.S.: Lopinavir; a potent drug against coronavirus infection: insight from molecular docking study. Arch Clin Infect Diseas 2017; 12: e13823. · doi:10.5812/archcid.13823
- Hopkins J.S.U.S.: drugmakers ship therapies to China, seeking to treat coronavirus. Wall Street J 2020; .
Cited by
Ciotti, M., Ciccozzi, M., Terrinoni, A., Jiang, W.-C., Wang, C.-B., & Bernardini, S. (2020) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2020.1783198 · Cited by 1,514
Artificial intelligence to deep learning: machine intelligence approach for drug discovery
Gupta, R., Srivastava, D., Sahu, M., Tiwari, S., Ambasta, R. K., & Kumar, P. (2021) · Molecular Diversity · doi:10.1007/s11030-021-10217-3 · Cited by 1,473
“Beck et al. 2020 conducted a study to predict commercially available antiviral drugs as a potential therapeutic agent against novel coronavirus (SARS-CoV-2) through DeepDTA [316].”
BackgroundChamola, V., Hassija, V., Gupta, V., & Guizani, M. (2020) · IEEE Access · doi:10.1109/access.2020.2992341 · Cited by 1,099
COVID-19: Transmission, prevention, and potential therapeutic opportunities
Lotfi, M., Hamblin, M. R., & Rezaei, N. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.05.044 · Cited by 1,016
Lalmuanawma, S., Hussain, J., & Chhakchhuak, L. (2020) · Chaos, Solitons & Fractals · doi:10.1016/j.chaos.2020.110059 · Cited by 845
Identification of Antiviral Drug Candidates against SARS-CoV-2 from FDA-Approved Drugs
Jeon, S., Ko, M., Lee, J., Choi, I., Byun, S. Y., Park, S., Shum, D., & Kim, S. (2020) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00819-20 · Cited by 675
Self-citationArtificial intelligence in COVID-19 drug repurposing
Zhou, Y., Wang, F., Tang, J., Nussinov, R., & Cheng, F. (2020) · The Lancet Digital Health · doi:10.1016/s2589-7500(20)30192-8 · Cited by 636
COVID-19: A promising cure for the global panic
Vellingiri, B., Jayaramayya, K., Iyer, M., Narayanasamy, A., Govindasamy, V., Giridharan, B., Ganesan, S., Venugopal, A., Venkatesan, D., Ganesan, H., et al. (2020) · Science of The Total Environment · doi:10.1016/j.scitotenv.2020.138277 · Cited by 636
Explainable Deep Learning for Pulmonary Disease and Coronavirus COVID-19 Detection from X-rays
Brunese, L., Mercaldo, F., Reginelli, A., & Santone, A. (2020) · Computer Methods and Programs in Biomedicine · doi:10.1016/j.cmpb.2020.105608 · Cited by 623
COVID-19 Patient Health Prediction Using Boosted Random Forest Algorithm
Iwendi, C., Bashir, A. K., Peshkar, A., Sujatha, R., Chatterjee, J. M., Pasupuleti, S., Mishra, R., Pillai, S., & Jo, O. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.00357 · Cited by 510
DeepPurpose: a deep learning library for drug–target interaction prediction
Huang, K., Fu, T., Glass, L. M., Zitnik, M., Xiao, C., & Sun, J. (2021) · Bioinformatics · doi:10.1093/bioinformatics/btaa1005 · Cited by 484
Deep learning and medical image processing for coronavirus (COVID-19) pandemic: A survey
Bhattacharya, S., Reddy Maddikunta, P. K., Pham, Q.-V., Gadekallu, T. R., Krishnan S, S. R., Chowdhary, C. L., Alazab, M., & Jalil Piran, M. (2021) · Sustainable Cities and Society · doi:10.1016/j.scs.2020.102589 · Cited by 483
Chen, Y. W., Yiu, C.-P. B., & Wong, K.-Y. (2020) · F1000Research · doi:10.12688/f1000research.22457.2 · Cited by 426
Pneumonia Classification Using Deep Learning from Chest X-ray Images During COVID-19
Ibrahim, A. U., Ozsoz, M., Serte, S., Al-Turjman, F., & Yakoi, P. S. (2024) · Cognitive Computation · doi:10.1007/s12559-020-09787-5 · Cited by 419
Pham, Q.-V., Nguyen, D. C., Huynh-The, T., Hwang, W.-J., & Pathirana, P. N. (2020) · IEEE Access · doi:10.1109/access.2020.3009328 · Cited by 413
“For example, the scientists in [12] developed a DL model to identify existing and commercial drugs for the ‘‘drug-repurposing’’ (also known as drug repositioning), i.”
BackgroundDeep learning in drug discovery: an integrative review and future challenges
Askr, H., Elgeldawi, E., Aboul Ella, H., Elshaier, Y. A. M. M., Gomaa, M. M., & Hassanien, A. E. (2023) · Artificial Intelligence Review · doi:10.1007/s10462-022-10306-1 · Cited by 390
C, S., S., D. K., Ragunathan, V., Tiwari, P., A., S., & P, B. D. (2022) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1815584 · Cited by 375
Artificial intelligence vs COVID-19: limitations, constraints and pitfalls
Naudé, W. (2020) · AI & SOCIETY · doi:10.1007/s00146-020-00978-0 · Cited by 368
Mapping the landscape of Artificial Intelligence applications against COVID-19
Bullock, J., Luccioni, A., Hoffman Pham, K., Sin Nga Lam, C., & Luengo-Oroz, M. (2020) · Journal of Artificial Intelligence Research · doi:10.1613/jair.1.12162 · Cited by 348
Liu, H., Ye, F., Sun, Q., Liang, H., Li, C., Li, S., Lu, R., Huang, B., Tan, W., & Lai, L. (2021) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2021.1873977 · Cited by 334
Chen, Y. W., Yiu, C.-P. B., & Wong, K.-Y. (2020) · F1000Research · doi:10.12688/f1000research.22457.1 · Cited by 323
Machine Learning and Artificial Intelligence in Pharmaceutical Research and Development: a Review
Kolluri, S., Lin, J., Liu, R., Zhang, Y., & Zhang, W. (2022) · The AAPS Journal · doi:10.1208/s12248-021-00644-3 · Cited by 286
da Silva, J. K. R., Figueiredo, P. L. B., Byler, K. G., & Setzer, W. N. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103426 · Cited by 284
Blockchain and AI-Based Solutions to Combat Coronavirus (COVID-19)-Like Epidemics: A Survey
Nguyen, D. C., Ding, M., Pathirana, P. N., & Seneviratne, A. (2021) · IEEE Access · doi:10.1109/access.2021.3093633 · Cited by 286
Leveraging Data Science to Combat COVID-19: A Comprehensive Review
Latif, S., Usman, M., Manzoor, S., Iqbal, W., Qadir, J., Tyson, G., Castro, I., Razi, A., Boulos, M. N. K., Weller, A., et al. (2020) · IEEE Transactions on Artificial Intelligence · doi:10.1109/tai.2020.3020521 · Cited by 270
Applications of artificial intelligence in battling against covid-19: A literature review
Tayarani N., M.-H. (2021) · Chaos, Solitons & Fractals · doi:10.1016/j.chaos.2020.110338 · Cited by 210
Artificial Intelligence for COVID-19: Rapid Review
(2020) · doi:10.2196/21476 · Cited by 160
A survey on deep transfer learning to edge computing for mitigating the COVID-19 pandemic
Sufian, A., Ghosh, A., Sadiq, A. S., & Smarandache, F. (2020) · Journal of Systems Architecture · doi:10.1016/j.sysarc.2020.101830 · Cited by 156
Lv, H., Shi, L., Berkenpas, J. W., Dao, F.-Y., Zulfiqar, H., Ding, H., Zhang, Y., Yang, L., & Cao, R. (2021) · Briefings in Bioinformatics · doi:10.1093/bib/bbab320 · Cited by 107
“Natural language processing MT-DTI to screen potential antivirals NA [27]”
A systematic review on AI/ML approaches against COVID-19 outbreak
Dogan, O., Tiwari, S., Jabbar, M. A., & Guggari, S. (2021) · Complex & Intelligent Systems · doi:10.1007/s40747-021-00424-8 · Cited by 87
Cao, L., & Liu, Q. (2022) · doi:10.1101/2022.08.22.22279022 · Cited by 49
Current State and Prospects of Artificial Intelligence in Allergy
van Breugel, M., Fehrmann, R. S. N., Bügel, M., Rezwan, F. I., Holloway, J. W., Nawijn, M. C., Fontanella, S., Custovic, A., & Koppelman, G. H. (2023) · Allergy · doi:10.1111/all.15849 · Cited by 43
Fighting COVID-19 with Artificial Intelligence
Monteleone, S., Kellici, T. F., Southey, M., Bodkin, M. J., & Heifetz, A. (2022) · Methods in molecular biology · doi:10.1007/978-1-0716-1787-8_3 · Cited by 17
Molecular epidemiology of SARS CoV-2: a review of current data on genetic variability of the virus
Parczewski, M., & Ciechanowicz, A. (2020) · Polish Archives of Internal Medicine · doi:10.20452/pamw.15550 · Cited by 17
Metadata
- Authors
- Beck, B. R., Shin, B., Choi, Y., Park, S., & Kang, K.
- Venue
- Computational and Structural Biotechnology Journal
- Published
- 2020
- Volume
- 18
- Pages
- 784-790
- ISSN
- 2001-0370 (ISSN-L)
- OpenAlex
- W3012994592
- Cited by
- 816
- References
- 32
- FWCI
- 83.02
- Type
- journal article
- Language
- en
- Open access
- gold
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 84 d)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.